INSIGHTS ON LIQUID DOSE MANUFACTURING
-
![GettyImages-2268874844-downstream-process-liquid-handling]( "Enhancing Biopharmaceutical Production Through Advanced Mixing")
Enhancing Biopharmaceutical Production Through Advanced MixingEliminate particulate contamination and product degradation in downstream bioprocessing. Learn how frictionless, levitating impeller technology ensures low-shear mixing and high yields.
-
![GettyImages-1316775813 fill finish pharmaceutical bottles]( "Fill-Finish Contract Manufacturing: Trends, Challenges, And The Future")
Fill-Finish Contract Manufacturing: Trends, Challenges, And The FutureSee why it's important to partner with a CDMO that’s investing in advanced sterile fill-finish capabilities to meet the demands of complex biologics, gene therapies, and mRNA-based products.
-
![Streamline Your Path To Clinical Fill]( "Streamline Your Path To Clinical Fill")
Streamline Your Path To Clinical FillDrug-independent PFS testing is a required early step — but it can be time-consuming and resource-intensive. What if you could eliminate the effort without losing the data you need?
-
![GettyImages-2217581928 manufacturing, production]( "Practical USP <1665>/<665> Guide To E&L Risk Assessment")
Practical USP <1665>/<665> Guide To E&L Risk AssessmentA practical USP <1665> and <665> framework helps manufacturers evaluate and manage extractables and leachables risk, supporting quality, safety, and regulatory compliance.
-
Upperton Capabilities Update April 2026: Fill/Finish4/28/2026
An inside look at a modern Annex 1–compliant sterile facility designed for flexible aseptic and terminally sterilised manufacturing across multiple drug delivery routes.
-
Bridging The Gap Between Product Readiness And Equipment Availability12/15/2025
Discover how manual precision at scale bridges packaging gaps, accelerates product launches, and ensures uninterrupted supply to deliver quality when automated equipment isn’t yet operational.
-
USP <788> Revisions And Why Packaging Matters More Than Ever5/12/2026
Prepare for the upcoming USP <788> revisions by strengthening your particulate control strategy to support regulatory compliance, product quality, and patient safety across injectable drug products.
-
NanoImprove The Performance Of Your Formulations9/24/2024
Learn how Nanoforming can help improve the performance of your molecule by increasing drug loads, improving bioavailability, enhancing drug delivery profiles, and supporting product differentiation.
-
Unlock Large-Volume Drug Delivery With Vertiva® On-Body Delivery System7/2/2026
See a large-volume drug delivery with a pre-filled, pre-loaded on-body device. Its programmable dosing profiles and reusable controller offer sustainable treatment while minimizing patient use errors.
LIQUID DOSE MANUFACTURING SOLUTIONS
-
![GettyImages-1411964582-scientist-microscope-testing-food-quality]( "Biologics: Development & Drug Substance Manufacturing")
Global partner delivering end‑to‑end drug development, manufacturing, and packaging with deep expertise, advanced facilities, and support across key modalities.
-
![IMA Cartoner, Model IC150C]( "Used IMA Pharmaceutical Cartoner: IC150C Model")
Used IMA cartoner, model IC150C, speeds up to 120 cartoners/minute, designed for pre glued cartons, 28 mm wide x 12 mm high x 55 mm long minimum carton size, 92 mm wide x 60 mm high x 190 mm long maximum carton size, with blister feeder, with leaflet inserter, Allen Bradley Micrologix 1500 plc with Panelview 550 HMI, Machine# B-92-024, built 2005.
-
![vials_set_clear]( "Vials")
Stevanato Group produces glass vials from Type I glass tube in different sizes and capacities, in bulk or ready-to-fill configuration. With full control over geometry and surface chemistry, our vials can be tailored to meet the different needs of biopharmaceutical customers.
-
![Automated Sys Of Tacome Product]( "Pharmaceutical Aseptic Filling Equipment")
AST’s ASEPTiCell® and GENiSYS® systems combine industry-proven technologies such as robotics and isolator-barrier systems to provide flexible pharmaceutical aseptic filling and closing of ready-to-use vials, syringes, and cartridges with a single machine. These innovative platforms use a modular design approach to provide a truly adaptive system with the capabilities and features necessary for cGMP production of clinical and commercial sterile injectable products.
-
![BD_Physioject_IMG_3332-450x300]( "BD Physioject™ Disposable Autoinjector")
BD Physioject™ Disposable Autoinjector offers a proven, user-friendly platform for self-injection, enhancing patient comfort, safety, and adherence across multiple chronic disease treatments globally.
